ArticleTechnical innovations & patient support in radiation oncology2026
Mid-ventilation PTV approach for stereotactic ablative body radiotherapy in stage I non-small-cell lung carcinoma: Implementation of a single-system workflow.
Article in Technical innovations & patient support in radiation oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: The Mid-Ventilation (MidV) approach is an alternative to internal target volume (ITV) for generating a planning target volume (PTV) in lung stereotactic ablative radiotherapy (SABR). It has been shown to reduce PTV and volume of normal lung tissue irradiated, whilst maintaining high local control rates. However, this approach has not been widely adopted due to difficulties in determining the MidV phase in commercially available treatment planning systems. We hypothesised that a fully integrated MidV workflow could be developed and validated within a single vendor platform, producing accurate contours and dosimetric improvements compared with the ITV based method. Methods: A MidV workflow was implemented using Eclipse/Aria, incorporating deformable image registration (DIR) of 4DCT images, automated 4D contour statistics for MidV phase selection and an embedded PTV margin calculation spreadsheet. Ten patients from a multi-centre Phase II lung SABR study were retrospectively analysed. The following metrics were used to compare the DIR method with the manually contoured iGTV: mean distance to agreement (MDA), dice similarity coefficient (DSC) and accurate selection of the MidV Phase (±10 %). Corresponding ITV and MidV PTV based plans were generated and compared using absolute PTV volumes, mean lung dose (MLD) and V20Gy. Results: DIR generated iGTVs demonstrated high geometric accuracy (mean MDA 0.86 mm; DSC 0.86). MidV phase selection aligned with manual selection in all patients. MidV based planning produced smaller PTVs than ITV based in 8/10 cases (mean 47.0 cm Conclusion: A streamlined, vendor integrated MidV workflow was successfully developed and validated, producing accurate DIR based contours and meaningful dosimetric reductions compared with ITV based method. These findings support broader clinical implementation of MidV based lung SABR.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.